OpenEvidence, a medical AI platform, has successfully raised $200 million in a Series C funding round, boosting its valuation to $6 billion. The round was spearheaded by Google Ventures, with significant contributions from Sequoia Capital and Kleiner Perkins. This marks a substantial increase from its previous valuation of $3.5 billion in July, when it raised $210 million. The platform, which provides verified medical answers, has seen its monthly consultations nearly double to 15 million since July, underscoring its growing influence in the medical AI sector.
OpenEvidence Secures $200M in Series C, Valued at $6B
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.